Filing Details
- Accession Number:
- 0001144204-13-060657
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-12 18:00:28
- Reporting Period:
- 2013-11-11
- Filing Date:
- 2013-11-12
- Accepted Time:
- 2013-11-12 18:00:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1138776 | Medgenics Inc. | MDGN | Biological Products, (No Disgnostic Substances) (2836) | 980217544 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1247015 | J Sol Barer | C/O Medgenics, Inc. 555 California Street, Suite 365 San Francisco CA 94104 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-11-11 | 25,000 | $6.80 | 72,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in two transactions at prices of $6.80 and $6.8053. The reporting person undertakes to provide Medgenics, Inc., any security holder of Medgenics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price set forth in this footnote.